Division of General Surgery, Trauma, and Surgical Critical Care, Department of Surgery, Yale School of Medicine, New Haven, Connecticut, USA.
Center for Health Services and Outcomes Research, Department of Surgery, Yale School of Medicine, New Haven, Connecticut, USA.
Surg Infect (Larchmt). 2023 Mar;24(2):190-198. doi: 10.1089/sur.2022.377. Epub 2023 Feb 8.
Trends in mortality, palliative care, and end-of-life care among critically ill patients with coronavirus disease 2019 (COVID-19) remain underreported. We hypothesized that use of palliative care and end-of-life care would increase over time, because improved understanding of the disease course and prognosis would potentially lead to more frequent use of these services. Adult patients with severe acute respiratory syndrome coronavirus 2 infection (SARS-CoV-2) during pandemic wave one (W1: March 2020 to September 2020) or wave two (W2: October 2020 to June 2021) admitted to an intensive care unit (ICU) in one of six northeastern U.S. hospitals were identified and clinical characteristics obtained. Vaccination data were unavailable. Outcomes of interest included mortality, palliative care consultation, and any end-of-life care (including hospice and comfort care). There were 1,904 critically ill patients with COVID-19: 817 (42.9%) in W1 and 1,087 (57.1%) in W2. Patients received mechanical ventilation more often during W1 than W2 (52.9% vs. 46.3%; p = 0.004), with no difference in ICU or hospital length of stay between waves. Mortality between W1 and W2 was similar (31.2% vs. 30.9%; p = 0.888). There was no difference in use of palliative care or any end-of-life care between waves. Patients who died during W2 versus W1 were more likely to have received both mechanical ventilation (77.1% vs. 67.1%; p = 0.007) and palliative care services (52.1% vs. 41.2%; p = 0.009). However, logistic regression adjusted for demographics, baseline comorbid disease, and clinical characteristics showed no difference in mortality (odds ratio [OR], 1.15; 95% confidence interval [CI], 0.89-1.48), palliative care (OR, 1.08; 95% CI, 0.84-1.40), or any end-of-life care (OR, 1.05; 95% CI, 0.82-1.34) in W2 versus W1. Mortality among critically ill patients with COVID-19 has remained constant across two pandemic waves with no change in use of palliative or end-of-life care.
在患有 2019 年冠状病毒病(COVID-19)的危重症患者中,死亡率、姑息治疗和临终关怀方面的趋势仍报道不足。我们假设随着时间的推移,姑息治疗和临终关怀的使用会增加,因为对疾病过程和预后的理解的提高可能会导致这些服务的更频繁使用。
在 6 家美国东北部医院的一个重症监护病房(ICU)中,确定了患有严重急性呼吸综合征冠状病毒 2 感染(SARS-CoV-2)的成年患者(波 1:2020 年 3 月至 2020 年 9 月;波 2:2020 年 10 月至 2021 年 6 月),并获得了临床特征。疫苗接种数据不可用。感兴趣的结果包括死亡率、姑息治疗咨询和任何临终关怀(包括临终关怀和舒适护理)。
有 1904 名患有 COVID-19 的危重症患者:波 1 中 817 名(42.9%),波 2 中 1087 名(57.1%)。在波 1 中,患者接受机械通气的频率高于波 2(52.9%比 46.3%;p=0.004),但两个波之间的 ICU 或住院时间长短没有差异。波 1 和波 2 之间的死亡率相似(31.2%比 30.9%;p=0.888)。两个波之间在姑息治疗或任何临终关怀的使用方面没有差异。与波 1 相比,在波 2 期间死亡的患者更有可能同时接受机械通气(77.1%比 67.1%;p=0.007)和姑息治疗服务(52.1%比 41.2%;p=0.009)。然而,经过调整人口统计学、基线合并症和临床特征的逻辑回归显示,在波 2 与波 1 相比,死亡率(比值比 [OR],1.15;95%置信区间 [CI],0.89-1.48)、姑息治疗(OR,1.08;95%CI,0.84-1.40)或任何临终关怀(OR,1.05;95%CI,0.82-1.34)方面没有差异。
在两次大流行波中,COVID-19 危重症患者的死亡率保持不变,姑息治疗或临终关怀的使用没有变化。